nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—CYP2E1—liver cancer	0.49	1	CbGaD
Dexfenfluramine—HTR2B—Sorafenib—liver cancer	0.161	0.374	CbGbCtD
Dexfenfluramine—HTR2C—Sorafenib—liver cancer	0.105	0.244	CbGbCtD
Dexfenfluramine—CYP2C19—Sorafenib—liver cancer	0.0414	0.0961	CbGbCtD
Dexfenfluramine—CYP1A2—Sorafenib—liver cancer	0.0382	0.0887	CbGbCtD
Dexfenfluramine—CYP2C9—Sorafenib—liver cancer	0.0345	0.0799	CbGbCtD
Dexfenfluramine—CYP2D6—Sorafenib—liver cancer	0.0315	0.0731	CbGbCtD
Dexfenfluramine—CYP2D6—Doxorubicin—liver cancer	0.0191	0.0443	CbGbCtD
Dexfenfluramine—CYP1A2—Metabolism—NR1H4—liver cancer	1.73e-05	0.000219	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTA1—liver cancer	1.72e-05	0.000219	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CG—liver cancer	1.72e-05	0.000218	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PSMA4—liver cancer	1.71e-05	0.000217	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PSMD10—liver cancer	1.71e-05	0.000217	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTA1—liver cancer	1.71e-05	0.000217	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NAT2—liver cancer	1.71e-05	0.000216	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTA3—liver cancer	1.7e-05	0.000216	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CRABP1—liver cancer	1.7e-05	0.000215	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NAT2—liver cancer	1.69e-05	0.000214	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CSF2—liver cancer	1.68e-05	0.000213	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—RAF1—liver cancer	1.67e-05	0.000212	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GOT2—liver cancer	1.67e-05	0.000211	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PIK3CD—liver cancer	1.66e-05	0.000211	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—H2AFX—liver cancer	1.65e-05	0.00021	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—IL2—liver cancer	1.65e-05	0.00021	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ALDOB—liver cancer	1.63e-05	0.000207	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GSTP1—liver cancer	1.63e-05	0.000207	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PIK3CB—liver cancer	1.63e-05	0.000207	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.63e-05	0.000206	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ALDOB—liver cancer	1.62e-05	0.000206	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—HMOX1—liver cancer	1.61e-05	0.000204	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CRABP1—liver cancer	1.56e-05	0.000198	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTA4—liver cancer	1.55e-05	0.000197	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CRABP1—liver cancer	1.55e-05	0.000196	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PRKCE—liver cancer	1.53e-05	0.000194	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.53e-05	0.000194	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.52e-05	0.000193	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTA2—liver cancer	1.51e-05	0.000192	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CD—liver cancer	1.51e-05	0.000192	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GSTM1—liver cancer	1.5e-05	0.000191	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL2—liver cancer	1.5e-05	0.00019	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TERT—liver cancer	1.49e-05	0.00019	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—HPGDS—liver cancer	1.48e-05	0.000188	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.47e-05	0.000187	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYCS—liver cancer	1.47e-05	0.000186	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTA1—liver cancer	1.46e-05	0.000185	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PIK3CB—liver cancer	1.45e-05	0.000184	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IGF2—liver cancer	1.45e-05	0.000184	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NAT2—liver cancer	1.44e-05	0.000183	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GGT1—liver cancer	1.44e-05	0.000182	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GOT1—liver cancer	1.44e-05	0.000182	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CYP1A1—liver cancer	1.42e-05	0.000181	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.39e-05	0.000177	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.39e-05	0.000176	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALDOB—liver cancer	1.39e-05	0.000176	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—KDR—liver cancer	1.37e-05	0.000173	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—HPGDS—liver cancer	1.36e-05	0.000173	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MAPK14—liver cancer	1.36e-05	0.000172	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CSF2—liver cancer	1.35e-05	0.000172	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—HPGDS—liver cancer	1.35e-05	0.000171	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—RAF1—liver cancer	1.35e-05	0.000171	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.34e-05	0.00017	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.34e-05	0.00017	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—H2AFX—liver cancer	1.33e-05	0.000169	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—IL2—liver cancer	1.33e-05	0.000169	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ESR1—liver cancer	1.33e-05	0.000169	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—MTHFR—liver cancer	1.33e-05	0.000168	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.32e-05	0.000168	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CRABP1—liver cancer	1.32e-05	0.000168	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PSMA4—liver cancer	1.32e-05	0.000168	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PSMD10—liver cancer	1.32e-05	0.000168	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CB—liver cancer	1.32e-05	0.000167	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—F2—liver cancer	1.32e-05	0.000167	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PPARA—liver cancer	1.3e-05	0.000165	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTP1—liver cancer	1.29e-05	0.000164	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GOT2—liver cancer	1.29e-05	0.000163	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—HMOX1—liver cancer	1.27e-05	0.000162	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CG—liver cancer	1.26e-05	0.00016	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—APC—liver cancer	1.26e-05	0.00016	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.22e-05	0.000155	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PSMA4—liver cancer	1.22e-05	0.000154	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PSMD10—liver cancer	1.22e-05	0.000154	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL2—liver cancer	1.21e-05	0.000153	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP2E1—liver cancer	1.21e-05	0.000153	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.21e-05	0.000153	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TERT—liver cancer	1.21e-05	0.000153	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PSMA4—liver cancer	1.2e-05	0.000153	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PSMD10—liver cancer	1.2e-05	0.000153	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.19e-05	0.000151	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTM1—liver cancer	1.19e-05	0.000151	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—BRAF—liver cancer	1.18e-05	0.00015	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GOT2—liver cancer	1.18e-05	0.00015	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GOT2—liver cancer	1.17e-05	0.000149	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.17e-05	0.000148	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—HPGDS—liver cancer	1.15e-05	0.000146	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.15e-05	0.000146	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYCS—liver cancer	1.13e-05	0.000143	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP1A1—liver cancer	1.13e-05	0.000143	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CG—liver cancer	1.12e-05	0.000141	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP2E1—liver cancer	1.11e-05	0.000141	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GOT1—liver cancer	1.11e-05	0.000141	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GGT1—liver cancer	1.11e-05	0.000141	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CD—liver cancer	1.11e-05	0.00014	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KDR—liver cancer	1.1e-05	0.00014	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP2E1—liver cancer	1.1e-05	0.00014	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—PIK3CA—liver cancer	1.1e-05	0.000139	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MAPK14—liver cancer	1.1e-05	0.000139	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SERPINE1—liver cancer	1.09e-05	0.000139	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—KRAS—liver cancer	1.08e-05	0.000137	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PPARG—liver cancer	1.08e-05	0.000137	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ESR1—liver cancer	1.07e-05	0.000136	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.07e-05	0.000135	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—F2—liver cancer	1.06e-05	0.000135	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—MTHFR—liver cancer	1.05e-05	0.000133	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.05e-05	0.000133	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYCS—liver cancer	1.04e-05	0.000132	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.03e-05	0.000131	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYCS—liver cancer	1.03e-05	0.000131	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PSMD10—liver cancer	1.03e-05	0.000131	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PSMA4—liver cancer	1.03e-05	0.000131	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PPARA—liver cancer	1.03e-05	0.000131	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GGT1—liver cancer	1.02e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GOT1—liver cancer	1.02e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CG—liver cancer	1.02e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—APC—liver cancer	1.02e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GOT1—liver cancer	1.01e-05	0.000128	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GGT1—liver cancer	1.01e-05	0.000128	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GOT2—liver cancer	1e-05	0.000127	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTP1—liver cancer	9.96e-06	0.000126	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PIK3CA—liver cancer	9.96e-06	0.000126	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—RAF1—liver cancer	9.88e-06	0.000125	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—HMOX1—liver cancer	9.83e-06	0.000125	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CD—liver cancer	9.8e-06	0.000124	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ALB—liver cancer	9.68e-06	0.000123	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MTOR—liver cancer	9.65e-06	0.000122	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CB—liver cancer	9.65e-06	0.000122	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—BRAF—liver cancer	9.55e-06	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP2E1—liver cancer	9.41e-06	0.000119	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HRAS—liver cancer	9.21e-06	0.000117	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTP1—liver cancer	9.17e-06	0.000116	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTM1—liver cancer	9.16e-06	0.000116	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.12e-06	0.000116	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTP1—liver cancer	9.09e-06	0.000115	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CDKN1B—liver cancer	9.05e-06	0.000115	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—HMOX1—liver cancer	9.04e-06	0.000115	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—HMOX1—liver cancer	8.96e-06	0.000114	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—AKT1—liver cancer	8.96e-06	0.000114	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CD—liver cancer	8.93e-06	0.000113	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CASP3—liver cancer	8.87e-06	0.000113	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL2—liver cancer	8.86e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PIK3CA—liver cancer	8.85e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SERPINE1—liver cancer	8.83e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL6—liver cancer	8.82e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CG—liver cancer	8.81e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYCS—liver cancer	8.81e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—KRAS—liver cancer	8.74e-06	0.000111	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP1A1—liver cancer	8.68e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GGT1—liver cancer	8.64e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GOT1—liver cancer	8.64e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCND1—liver cancer	8.64e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—JUN—liver cancer	8.62e-06	0.000109	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CTNNB1—liver cancer	8.55e-06	0.000108	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CB—liver cancer	8.55e-06	0.000108	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PPARG—liver cancer	8.51e-06	0.000108	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTM1—liver cancer	8.42e-06	0.000107	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MMP9—liver cancer	8.39e-06	0.000106	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CDKN1A—liver cancer	8.36e-06	0.000106	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTM1—liver cancer	8.35e-06	0.000106	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MAPK8—liver cancer	8.16e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—AKT1—liver cancer	8.13e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—MTHFR—liver cancer	8.09e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CA—liver cancer	8.03e-06	0.000102	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP1A1—liver cancer	7.98e-06	0.000101	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—RAF1—liver cancer	7.97e-06	0.000101	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PPARA—liver cancer	7.94e-06	0.000101	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP1A1—liver cancer	7.92e-06	0.0001	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CB—liver cancer	7.78e-06	9.87e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MTOR—liver cancer	7.78e-06	9.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTP1—liver cancer	7.76e-06	9.85e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CD—liver cancer	7.75e-06	9.83e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—HMOX1—liver cancer	7.66e-06	9.71e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ALB—liver cancer	7.65e-06	9.7e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—VEGFA—liver cancer	7.53e-06	9.55e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—STAT3—liver cancer	7.46e-06	9.46e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—MTHFR—liver cancer	7.44e-06	9.44e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HRAS—liver cancer	7.43e-06	9.43e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—MTHFR—liver cancer	7.38e-06	9.36e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CDKN1B—liver cancer	7.3e-06	9.27e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PPARA—liver cancer	7.3e-06	9.26e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PPARA—liver cancer	7.24e-06	9.18e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—AKT1—liver cancer	7.23e-06	9.17e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CASP3—liver cancer	7.16e-06	9.08e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL2—liver cancer	7.15e-06	9.07e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTM1—liver cancer	7.14e-06	9.05e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.13e-06	9.05e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL6—liver cancer	7.11e-06	9.02e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCND1—liver cancer	6.97e-06	8.84e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—JUN—liver cancer	6.95e-06	8.82e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MYC—liver cancer	6.93e-06	8.79e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TGFB1—liver cancer	6.91e-06	8.77e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CTNNB1—liver cancer	6.9e-06	8.75e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CG—liver cancer	6.8e-06	8.62e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MMP9—liver cancer	6.77e-06	8.58e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP1A1—liver cancer	6.76e-06	8.58e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CB—liver cancer	6.75e-06	8.57e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CDKN1A—liver cancer	6.74e-06	8.55e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MAPK8—liver cancer	6.58e-06	8.35e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PPARG—liver cancer	6.56e-06	8.32e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—AKT1—liver cancer	6.56e-06	8.32e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.5e-06	8.25e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—KRAS—liver cancer	6.4e-06	8.12e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—MTHFR—liver cancer	6.31e-06	8e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CG—liver cancer	6.25e-06	7.93e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CG—liver cancer	6.2e-06	7.86e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PPARA—liver cancer	6.19e-06	7.85e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—VEGFA—liver cancer	6.07e-06	7.71e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PPARG—liver cancer	6.04e-06	7.66e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—STAT3—liver cancer	6.02e-06	7.63e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PPARG—liver cancer	5.98e-06	7.59e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CD—liver cancer	5.98e-06	7.58e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ALB—liver cancer	5.9e-06	7.48e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CA—liver cancer	5.88e-06	7.46e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TP53—liver cancer	5.69e-06	7.22e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MYC—liver cancer	5.59e-06	7.09e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TGFB1—liver cancer	5.58e-06	7.07e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.56e-06	7.05e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CD—liver cancer	5.5e-06	6.97e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CD—liver cancer	5.45e-06	6.91e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HRAS—liver cancer	5.44e-06	6.9e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ALB—liver cancer	5.43e-06	6.88e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ALB—liver cancer	5.38e-06	6.82e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CG—liver cancer	5.3e-06	6.72e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CB—liver cancer	5.21e-06	6.61e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CA—liver cancer	5.21e-06	6.61e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL6—liver cancer	5.21e-06	6.61e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KRAS—liver cancer	5.16e-06	6.55e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PPARG—liver cancer	5.11e-06	6.49e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKT1—liver cancer	4.8e-06	6.09e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CB—liver cancer	4.79e-06	6.08e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CB—liver cancer	4.75e-06	6.03e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CA—liver cancer	4.74e-06	6.02e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CD—liver cancer	4.66e-06	5.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALB—liver cancer	4.6e-06	5.83e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TP53—liver cancer	4.59e-06	5.82e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HRAS—liver cancer	4.39e-06	5.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AKT1—liver cancer	4.26e-06	5.4e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL6—liver cancer	4.2e-06	5.33e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CA—liver cancer	4.12e-06	5.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CB—liver cancer	4.06e-06	5.15e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKT1—liver cancer	3.88e-06	4.92e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AKT1—liver cancer	3.36e-06	4.27e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CA—liver cancer	3.18e-06	4.03e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CA—liver cancer	2.92e-06	3.71e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CA—liver cancer	2.9e-06	3.67e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AKT1—liver cancer	2.59e-06	3.29e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CA—liver cancer	2.47e-06	3.14e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AKT1—liver cancer	2.39e-06	3.03e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AKT1—liver cancer	2.37e-06	3e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKT1—liver cancer	2.02e-06	2.56e-05	CbGpPWpGaD
